SFS
ANVS icon

Sowell Financial Services’s Annovis Bio ANVS Stock Holding History

Sowell Financial Services’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,529
Closed -$12K – 3095
2020
Q4 		$12K Buy
+1,529
New +$8.28K ﹤0.01% 1932

Other funds holding ANVS

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Sowell Financial Services's ANVS Position: Q1 2021 in Review

Sowell Financial Services sold out of Annovis Bio (ANVS) in Q1 2021, closing a stake of 1,529 shares — an estimated $12K sold.

Sowell Financial Services first reported a position in ANVS in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 31 funds tracked by Wall St. Rank hold ANVS as of Q1 2021.

  • Sowell Financial Services reported no remaining Annovis Bio position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,529 Annovis Bio shares in Q1 2021, an estimated $12K.
  • Sowell Financial Services first reported a position in Annovis Bio in Q4 2020 and held it in 1 quarter.
  • Sowell Financial Services's Annovis Bio position peaked at $12K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.